Emanuel Stutz Selected Research

Angiosarcoma of the breast

11/2021	Comment on Kronenfeld et al. Clinical Outcomes for Primary and Radiation-Associated Angiosarcoma of the Breast with Multimodal Treatment: Long-Term Survival Is Achievable. Cancers 2021, 13, 3814.
8/2021	Radiation-Associated Angiosarcoma of the Breast and Chest Wall Treated with Thermography-Controlled, Contactless wIRA-Hyperthermia and Hypofractionated Re-Irradiation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Emanuel Stutz Research Topics

Disease

6	Hyperthermia 02/2022 - 01/2019
3	Neoplasms (Cancer) 08/2021 - 02/2014
2	Angiosarcoma of the breast 11/2021 - 08/2021
2	Urinary Bladder Neoplasms (Bladder Cancer) 01/2021 - 01/2019
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2019 - 01/2017
2	Prostatic Neoplasms (Prostate Cancer) 07/2018 - 11/2017
1	Sarcoma (Soft Tissue Sarcoma) 10/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2020
1	Lung Neoplasms (Lung Cancer) 02/2014

Drug/Important Bio-Agent (IBA)

1	Dihydrotachysterol (AT 10)IBA 10/2021
1	Immunologic Factors (Immunomodulators)IBA 01/2019
1	saracatinibIBA 02/2014
1	5- ((2,6- dichlorobenzyl)sulfonyl)- 3- ((3,5- dimethyl- 4- ((2- (pyrrolidin- 1- ylmethyl)pyrrolidin- 1- yl)carbonyl)- 1H- pyrrol- 2- yl)methylene)- 1,3- dihydro- 2H- indol- 2- oneIBA 02/2014
1	CrizotinibIBA 02/2014

Therapy/Procedure

9	Radiotherapy 02/2022 - 01/2017
2	Chemoradiotherapy 01/2019 - 01/2017
1	Combined Modality Therapy 11/2021
1	Neoadjuvant Therapy 10/2021
1	Re-Irradiation 08/2021
1	Induced Hyperthermia (Thermotherapy) 01/2019
1	Drug Therapy (Chemotherapy) 01/2019